119th Congress · introduced in the Senate · Mar 5, 2025
Royalty Transparency Act
Official title from Congress.gov
Latest action (Sep 17, 2025): Placed on Senate Legislative Calendar under General Orders. Calendar No. 165.
View on Congress.govPolicy area: Government Operations and Politics
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 165.
Committee on Homeland Security and Governmental Affairs. Reported by Senator Paul with amendments. Without written report.
Committee on Homeland Security and Governmental Affairs. Reported by Senator Paul with amendments. Without written report.
Committee on Homeland Security and Governmental Affairs. Ordered to be reported without amendment favorably.
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Introduced in Senate
Actions from Congress.gov, newest first.
Congressional oversight · Government employee pay, benefits, personnel management · Government ethics and transparency, public corruption · Government information and archives · Intellectual property · Public contracts and procurement
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
7 citations.
ASSOCIATION OF AMERICAN MEDICAL COLLEGES · lobbying firm or registrant: ASSOCIATION OF AMERICAN MEDICAL COLLEGES
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Medical/Disease Research/Clinical Labs
$431,446
Spent on own lobbying
…NIH). H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Support efforts to ensure the National Institutes of Health (NIH) peer review system is not hampered. Issue: Avoid unnecessar…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSOCIATION OF AMERICAN MEDICAL COLLEGES · lobbying firm or registrant: ASSOCIATION OF AMERICAN MEDICAL COLLEGES
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 17, 2026 · issue area: Medical/Disease Research/Clinical Labs
$821,438
Spent on own lobbying
…NIH). H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Support efforts to ensure the National Institutes of Health (NIH) peer review system is not hampered. Issue: Avoid unnecessar…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSOCIATION OF AMERICAN MEDICAL COLLEGES · lobbying firm or registrant: ASSOCIATION OF AMERICAN MEDICAL COLLEGES
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 16, 2026 · issue area: Medical/Disease Research/Clinical Labs
$577,720
Spent on own lobbying
…NIH). H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Support efforts to ensure the National Institutes of Health (NIH) peer review system is not hampered. H.Res.708 - Recognizing…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSOCIATION OF AMERICAN MEDICAL COLLEGES · lobbying firm or registrant: ASSOCIATION OF AMERICAN MEDICAL COLLEGES
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Medical/Disease Research/Clinical Labs
$708,395
Spent on own lobbying
…NIH). H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Support efforts to ensure the National Institutes of Health (NIH) peer review system is not hampered. H.Res.708 - Recognizing…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSOCIATION OF AMERICAN MEDICAL COLLEGES · lobbying firm or registrant: ASSOCIATION OF AMERICAN MEDICAL COLLEGES
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 19, 2025 · issue area: Medical/Disease Research/Clinical Labs
$758,175
Spent on own lobbying
…NIH). H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Ensure bill does not hamper the National Institutes of Health (NIH) peer review system. H.Res.708 - Recognizing the contribut…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSOCIATION OF AMERICAN MEDICAL COLLEGES · lobbying firm or registrant: ASSOCIATION OF AMERICAN MEDICAL COLLEGES
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 17, 2025 · issue area: Medical/Disease Research/Clinical Labs
$831,429
Spent on own lobbying
…orks. H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Support technical correction to ensure bill does not hamper the National Institutes of Health (NIH) peer review system.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ASSOCIATION OF AMERICAN MEDICAL COLLEGES · lobbying firm or registrant: ASSOCIATION OF AMERICAN MEDICAL COLLEGES
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 21, 2025 · issue area: Medical/Disease Research/Clinical Labs
$750,957
Spent on own lobbying
…orks. H.R.1864/S.854 - Risky Research Review Act Issue: Support prevention of unintended consequences from new restrictions on life sciences research. H.R.1863/S.855 - Royalty Transparency Act Issue: Support technical correction to ensure bill does not paralyze National Institutes of Health (NIH) peer review system.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing